Can Current Drug Therapy Prevent Beta Cell Failure and Bring Treatment Durability in T2DM?
Posted July 20, 2011 by John L. Leahy, MDA hot topic in the type 2 diabetes world is whether we have in hand the tools to stop the decline in beta cell function that typifies this disease and, consequently, a therapy or therapies that successfully control blood glucose for many years – so-called treatment durability. Actually this is three topics. What are the specific mechanisms for the beta cell failure? Do any of our existing therapies, or those on the drawing board, reverse these mechanisms to slow or stop the beta cell failure?